272 related articles for article (PubMed ID: 17170123)
21. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
22. Recombinant Tissue Plasminogen Activator (r-tPA) Induces In-Vitro Human Neutrophil Migration via Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1).
Liberale L; Bertolotto M; Minetti S; Contini P; Verzola D; Ameri P; Ghigliotti G; Pende A; Camici GG; Carbone F; Montecucco F
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977685
[TBL] [Abstract][Full Text] [Related]
23. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
24. Tissue-type plasminogen activator induces TNF-α-mediated preconditioning of the blood-brain barrier.
Diaz A; Woo Y; Martin-Jimenez C; Merino P; Torre E; Yepes M
J Cereb Blood Flow Metab; 2022 Apr; 42(4):667-682. PubMed ID: 34796748
[TBL] [Abstract][Full Text] [Related]
25. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
[TBL] [Abstract][Full Text] [Related]
26. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
27. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.
Su EJ; Fredriksson L; Geyer M; Folestad E; Cale J; Andrae J; Gao Y; Pietras K; Mann K; Yepes M; Strickland DK; Betsholtz C; Eriksson U; Lawrence DA
Nat Med; 2008 Jul; 14(7):731-7. PubMed ID: 18568034
[TBL] [Abstract][Full Text] [Related]
28. Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia.
Deguchi K; Liu N; Liu W; Omote Y; Kono S; Yunoki T; Deguchi S; Yamashita T; Ikeda Y; Abe K
J Neurosci Res; 2014 Nov; 92(11):1509-19. PubMed ID: 24938625
[TBL] [Abstract][Full Text] [Related]
29. PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.
Gonias SL; Banki MA; Gilder AS; Azmoon P; Campana WM; Mantuano E
J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29930084
[TBL] [Abstract][Full Text] [Related]
30. Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1.
Kim JW; Lee SH; Ko HM; Kwon KJ; Cho KS; Choi CS; Park JH; Kim HY; Lee J; Han SH; Ignarro LJ; Cheong JH; Kim WK; Shin CY
Neurochem Int; 2011 Feb; 58(3):423-33. PubMed ID: 21193004
[TBL] [Abstract][Full Text] [Related]
31. LRP and alphavbeta3 mediate tPA activation of smooth muscle cells.
Akkawi S; Nassar T; Tarshis M; Cines DB; Higazi AA
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1351-9. PubMed ID: 16489109
[TBL] [Abstract][Full Text] [Related]
32. New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system.
Yepes M; Lawrence DA
Exp Biol Med (Maywood); 2004 Dec; 229(11):1097-104. PubMed ID: 15564435
[TBL] [Abstract][Full Text] [Related]
33. Antibody-mediated inhibition of tissue-type plasminogen activator binding to the low-density lipoprotein receptor-related protein 1 as a potential beneficial modulator for stroke therapy.
Klecker PH; Fritzen L; Mazura AD; Weggen S; Pietrzik CU
J Cell Biochem; 2023 Jul; 124(7):1040-1049. PubMed ID: 37288821
[TBL] [Abstract][Full Text] [Related]
34. Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism.
Lemarchand E; Maubert E; Haelewyn B; Ali C; Rubio M; Vivien D
Cell Death Differ; 2016 Jan; 23(1):123-31. PubMed ID: 26068590
[TBL] [Abstract][Full Text] [Related]
35. Tissue plasminogen activator in the amygdala: a new role for an old protease.
Skrzypiec AE; Buczko W; Pawlak R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 8():135-46. PubMed ID: 19258671
[TBL] [Abstract][Full Text] [Related]
36. Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity.
Cho KS; Kwon KJ; Choi CS; Jeon SJ; Kim KC; Park JH; Ko HM; Lee SH; Cheong JH; Ryu JH; Han SH; Shin CY
Glia; 2013 May; 61(5):694-709. PubMed ID: 23378038
[TBL] [Abstract][Full Text] [Related]
37. Elevation of mRNA levels of tissue-type plasminogen activator and urokinase-type plasminogen activator in hippocampus and cerebral cortex following middle cerebral artery occlusion in rats.
Ito T; Takenaka K; Sakai H; Yoshimura S; Hayashi K; Noda S; Sakai N
Neurol Res; 2000 Jun; 22(4):413-9. PubMed ID: 10874693
[TBL] [Abstract][Full Text] [Related]
38. Rat liver sinusoidal endothelial cells (LSECs) express functional low density lipoprotein receptor-related protein-1 (LRP-1).
Øie CI; Appa RS; Hilden I; Petersen HH; Gruhler A; Smedsrød B; Hansen JB
J Hepatol; 2011 Dec; 55(6):1346-52. PubMed ID: 21703209
[TBL] [Abstract][Full Text] [Related]
39. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.
Jin R; Yang G; Li G
Neurobiol Dis; 2010 Jun; 38(3):376-85. PubMed ID: 20302940
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal Stromal Cells Promote Axonal Outgrowth Alone and Synergistically with Astrocytes via tPA.
Qian JY; Chopp M; Liu Z
PLoS One; 2016; 11(12):e0168345. PubMed ID: 27959956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
